Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
filgrastim | Injection | 300 mcg/ml | |
letrozol | tablet | 2.5 mg | |
flutamide | tablet | 250 mg | |
tamoxifen | tablet | 20 mg (as citrate) | |
leuprorelin | Injection | 3.75 mg (acetate) | |
interferon alpha 2B | Injection | 18 000 000 UI | |
BCG from Calmette-Guerin strain | Injection | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
cyclophosphamide | tablet | 50 mg | |
cyclophosphamide | Injection | 500 mg | |
chlorambucil | tablet | 2 mg | |
melphalan | tablet | 2 mg | |
ifosfamide | Injection | 1 g | |
dacarbazine | Injection | 200 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
vinblastine | Injection | 10 mg | |
vincristine | Injection | 1 mg/mL | |
etoposide | Injection | 20 mg/mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
gemcitabine | Injection | 1g (chlorohydrate) | |
fluorouracil | Injection | 500mg/10ml | |
citarabine | Injection | 500 mg | |
citarabine | Injection | 100 mg | |
capecitabine | tablet | 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
mercaptopurine | tablet | 50 mg | |
fludarabine | Injection | 50 mg (phosphate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
dactinomycin | Solution for injection | 0.5 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
methotrexate | Solution for injection | 25 mg/ ml | |
methotrexate | Injection | 500mg (sodium) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
doxorubicin | Powder for injection | 50 mg (hydrochloride) in vial | |
mitoxantrone | Injection | 2 mg/mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
imatinib | tablet | 100 mg (as mesylate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
rituximab | Solution for injection | 10 mg/ ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
asparaginase | Injection | 10000 UI | |
hydroxyurea | capsule | 500 mg | |
retinoic acid | capsule | 10 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
cisplatin | Injection | 50 mg | |
carboplatin | Injection | 150 mg | |
carboplatin | Injection | 450 mg | |
oxaliplatin | Injection | 100 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
paclitaxel | Powder for injection | 6 mg/ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
filgrastim | Injection | 300 mcg/ml | |
interferon alpha 2B | Injection | 18 000 000 UI |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
mycophenolate mofetil | tablet | 250 mg | |
leflunomide | tablet | 20 mg | |
basiliximab | Injection | 10 mg | |
cyclosporine | Solution | 100 mg/ml | |
tacrolimus | tablet | 1 mg | |
azathioprine | tablet | 50 mg | |
talidomida | tablet | 100 mg | |
methotrexate | tablet | 2.5 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
doxycycline | capsule | 100 mg (as hydrochloride or hyclate) | |
Chloranfenicol | capsule | 1 gr (sodium succinate) | |
ampicillin | Powder for injection | 1 g (as sodium salt) in vial | |
amoxicillin | tablet | 500 mg | |
amoxicillin | oral liquid | 250 mg/5 mL | |
penicillin G (Sodium) | Powder for injection | 5 MUI | |
benzathine benzylpenicillin | Injection | 1 200 000 IU | |
dicloxacillin | tablet | 250mg | |
oxacillin | Injection | 1g | |
ampicillin + sulbactam | Powder for injection | 1 g (sodium) + 0.5 g (sodium) | |
amoxicillin + clavulanic acid | tablet | 500mg + 125mg | |
amoxicillin + clavulanic acid | oral liquid | 250 mg amoxicillin + 62.5 mg clavulanic acid/5 ml | |
piperacillin sodium + tazobactum sodium | Solution for injection | 4 g/ 500 mg | |
cefazolin | Injection | 1g | |
cefadroxil | capsule | 500mg | |
cefadroxil | oral liquid | 250mg/5ml | |
cefotaxime | Injection | 1 g | |
ceftazidime | Powder for injection | 1 g (as pentahydrate) in vial | |
ceftriaxone | Powder for injection | 1 g (as sodium salt) in vial | |
meropenem | Powder for injection | 500mg | |
meropenem | Powder for injection | 1 g | |
imipenem + cilastatin | Powder for injection | 500 mg (as monohydrate) + 500 mg (as sodium salt) in vial | |
sulfadiazine | tablet | 500 mg | |
sulfamethoxazole + trimethoprim | tablet | 800 mg + 160 mg | |
sulfamethoxazole + trimethoprim | oral liquid | 200 mg + 40 mg/5 mL | |
clarithromycin | tablet | 500 mg | |
clarithromycin | Suspension | 250 mg/5 ml | |
azithromycin | tablet | 500 mg | |
azithromycin | oral liquid | 200 mg/5 mL | |
clindamycin | tablet | 300 mg | |
clindamycin | oral liquid | 75 mg/5 mL (as palmitate) | |
clindamycin | Injection | 150 mg (as phosphate)/mL | |
streptomycin | Powder for injection | 1 g (as sulfate) in vial | |
gentamicin | Injection | 40 mg/ml | |
kanamycin | Powder for injection | 1 g (as sulfate) in vial | |
kanamycin | Injection | 500 mg | |
amikacin | Injection | 250 mg/ml | |
ciprofloxacin | tablet | 500mg (as chlorohydrate) | |
ciprofloxacin | Injection | 2mg (lactate)/ml | |
levofloxacin | Injection | 500 mg | |
levofloxacin | Injection | 5 mg/ ml | |
moxifloxacin | tablet | 400 mg | |
vancomycin | Injection | 500 mg (chlorohydrate) | |
metronidazole | Injection | 5 mg/mL | |
nitrofurantoin | tablet | 100 mg | |
nitrofurantoin | oral suspension | 50mg/5ml | |
phosphomycin | capsule | 500 mg | |
linezolid | tablet | 600 mg | |
linezolid | Solution for IV infusion | 2 mg/ ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
p-aminosalicylic acid | tablet | 500 mg | |
p-aminosalicylic acid | granules | 4 g in sachet | |
cycloserine | capsule | 250 mg | |
rifampicin | capsule | 300 mg | |
rifampicin | Suspension | 100mg/5ml | |
isoniazid | tablet | 100mg | |
isoniazid | tablet | 300mg | |
isoniazid | oral liquid | 50 mg/5 ml | |
ethionamide | tablet | 250 mg | |
ethionamide | tablet | 500 mg | |
pyrazinamide | tablet | 500 mg | |
ethambutol | tablet | 400mg (chlorohydrate) | |
isoniazid + rifampicin | tablet | 150 mg + 150 mg | |
ethambutol + isoniazid + pyrazinamide + rifampicin | tablet | 275 mg + 75 mg + 400 mg + 150 mg | |
clofazimine | capsule | 50 mg | |
clofazimine | capsule | 100 mg | |
dapsone | tablet | 100 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amphotericin B | Injection | 50 mg | |
fluconazole | Injection | 200 mg | |
fluconazole | capsule | 50 mg | |
fluconazole | Injection | 2 mg/mL in vial | |
itraconazole | tablet | 100 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
aciclovir | tablet | 400 mg | |
aciclovir | tablet | 250 mg | |
aciclovir | oral liquid | 200 mg/5 mL | |
ganciclovir | Injection | 500 mg (sodium) | |
indinavir (IDV) | solid oral dosage form | 400 mg (as sulfate) | |
ritonavir | oral liquid | 400 mg/5 ml | |
ritonavir | capsule | 100 mg | |
nelfinavir | tablet | 250mg (as mesylate) | |
nelfinavir | oral liquid | 50mg (mesylate)/g | |
atazanavir | solid oral dosage form | 300 mg (as sulfate) | |
darunavir | tablet | 600 mg | |
zidovudine (ZDV or AZT) | capsule | 100 mg | |
zidovudine (ZDV or AZT) | capsule | 300 mg | |
zidovudine (ZDV or AZT) | Suspension | 10 mg/ml | |
zidovudine (ZDV or AZT) | Suspension | 50 mg/5 ml | |
didanosine (ddI) | capsule (unbuffered enteric-coated) | 125 mg | |
didanosine (ddI) | capsule (unbuffered enteric-coated) | 250 mg | |
didanosine (ddI) | capsule (unbuffered enteric-coated) | 400 mg | |
didanosine (ddI) | powder for oral administration | 4g | |
estavudina | capsule | 30 mg | |
stavudine (d4T) | capsule | 20 mg | |
stavudine (d4T) | powder for oral liquid | 5 mg/5 ml | |
lamivudine (3TC) | tablet | 150 mg | |
lamivudine (3TC) | oral liquid | 50 mg/5 ml | |
abacavir (ABC) | tablet | 300 mg (as sulfate) | |
tenofovir disoproxil fumarate | tablet | 300 mg | |
nevirapine (NVP) | tablet | 200 mg | |
nevirapine (NVP) | oral liquid | 50 mg/5 ml | |
efavirenz (EFV or EFZ) | tablet | 600 mg | |
etravirine | tablet | 100 mg | |
efavirenz (EFV or EFZ) | capsule | 200 mg | |
efavirenz (EFV or EFZ) | tablet | 600 mg | |
oseltamivir | capsule | 75 mg (as phosphate) | |
lamivudine + zidovudine | tablet | 150 mg + 300 mg | |
emtricitabine + tenofovir | tablet | 200 mg + 300 mg | |
efavirenz + emtricitabine + tenofovir | tablet | 600 mg + 200 mg + 300 mg | |
lopinavir + ritonavir (LPV/r) | tablet | 200 mg/ 50 mg | |
lopinavir + ritonavir (LPV/r) | oral liquid | 80 + 20 mg/ml | |
raltegavir | tablet | 400 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ophidic antivenom | Solution for injection | N/A | |
anti-D immunoglobulin (human) | Injection | 300 mcg/ ml | |
human normal immunoglobulin | injectable solution | 1 gr | |
human normal immunoglobulin | injectable solution | (5 - 6) g | |
anti rabies human serum | Solution for injection | 150 UI/ ml | |
antitetanus immunoglobulin (human) | intramuscular administration | 250 IU per vial |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
DTP vaccine | Injection | Injectiondiphtheria-tetanus toxoid + whole inactivated B. pertussis cells | |
Tdap Acellular Triple Antibacterial Vaccine | Injection | D2LF, P2.5mcg,T5LF | |
pneumococcal vaccine -23 | Solution for injection | 0.5 mL - 1 dose | |
pneumococcal vaccine 13 valente | suspension inyectable | N/A | |
pneumococcal vaccine 10 valente | suspension inyectable | N/A | |
DT vaccine | Injection | N/A | |
Td Difteria Toxoid + Tetanus adsorbe vaccine | Injection | N/A | |
Trivalent anti-influenza vaccine | Injection | 0.5 mL (A+B+Subviron, Timerosal) | |
hepatitis B vaccine | N/A | N/A | |
measles vaccine | N/A | N/A | |
poliomyelitis vaccine | Injection | N/A | |
polyomelitis bivalent vaccine | Injection | 0.1 mL | |
cell-culture rabies vaccine | Injection | N/A | |
Vero cells purified rabies vaccine | Injection | N/A | |
monovalent human atenuate rotavirus vaccine | Injection | 1 mL | |
yellow fever vaccine | N/A | N/A | |
pentavalent vaccine | Injection | diphtheria-tetanu toxoid, whole cell pertussis, hepatitis B, H. influenzae b (Hib) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
mebendazole | tablet | 100 mg | |
mebendazole | Suspension | 100mg/5ml | |
albendazole | tablet | 200mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
metronidazole | tablet | 500 mg | |
metronidazole | Suspension | 250 mg/5 mL | |
diloxanide | tablet | 500 mg (furoate) | |
diloxanide | oral suspension | (200-250)mg/5mL | |
chloroquine | tablet | 150mg (phosphate) | |
hydroxychloroquine | tablet | 400mg (sulfate) or 310mg (pure) | |
primaquine | tablet | 15 mg (phosphate) | |
benznidazole | tablet | 100 mg | |
meglumine antimoniate | Injection | 300mg/ml | |
nifurtimox | tablet | 120 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
permethrin | Lotion | 1% | |
permethrin | cream | 5% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
sodium fusidate | Ointment | 2% (20 mg/g) | |
neomycin + bacitracin | cream | 5 mg (5000 UI) + 5 mg (250 UI) | |
silver sulfadiazine | cream | 1% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
clotrimazole | cream | 1% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
methoxsalen | tablet | 10 mg | |
methoxsalen | Solution | 0.4% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
aluminum aulfate and aalcium acetate | Solution | (36.4 + 51.8) % | |
nitrofurazone | cream | 0.2% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
tretinoin | cream | 0.05 g |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
hydrocortisone | cream | 1% (acetate) | |
betamethasone | cream | 0.1% (as valerate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
Chloranfenicol | eye drops | 0.5% | |
Chloranfenicol | eye drops | 1% | |
tobramycin | dro | 0.3% x 5 ml | |
chloranfenicol + dexametasone phosphate | eye drops | 0.3%+0.1% | |
Oxitetracycline+Polymyxine B | eye drops | (5 mg +10,000 U.I)/g | |
aciclovir | Eye ointment | 3% | |
ciprofloxacin | topical | 0.3% drops (as hydrochloride) | |
prednisolone | solution (eye drops) | 1% (acetate) | |
diclofenac | solution (eye drops) | 0.1% (sodium) | |
tobramycin + dexamethasone | dro | 0.3%/ 0.1% x 5 ml | |
latanoprost | solution (eye drops) | 0.005% | |
pilocarpine | solution (eye drops) | 2% (hydrochloride or nitrate) | |
Carbacol | eye drops | 0.01% | |
acetazolamide | tablet | 250 mg | |
dorzolamide | solution (eye drops) | 2% | |
timolol | solution (eye drops) | 0.5% (maleate) | |
atropine | solution (eye drops) | 0.5-1% | |
cyclopentolate | solution (eye drops) | 1% (hydrochloride) | |
tropicamide | solution (eye drops) | 0.5% | |
tropicamide | solution (eye drops) | 1% | |
phenylephrine+tropicamide | solution (eye drops) | 0.8% - 5 mL. | |
phenylephrine | dro | 10% | |
cromoglycate | solution (eye drops) | 2% (sodium) | |
tetracaine | solution (eye drops) | 0.5% (hydrochloride) | |
normal saline | solution (eye drops) | 500 mL | |
artificial tears | solution (eye drops) | 0.3% to 1% | |
Polyacrilic acid | eye drops | 0.2% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
glycerine | N/A | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
fludrocortisone | tablet | 0.1 mg | |
dexamethasone | Injection | 4 mg/mL | |
methylprednisolone | Injection | 500 mg (sodium succinate) | |
methylprednisolone | Injection | 1 gm | |
methylprednisolone | tablet | 40 mg | |
prednisolone | tablet | 5 mg | |
prednisone | tablet | 50 mg | |
triamcinolone | Injection | 10 mg/mL in 5-mL vial | |
hydrocortisone | suspension inyectable | 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
desmopressin | nasal solution | 0.1 mg (acetate)/mL | |
oxytocin | Injection | 5 IU/mL | |
octreotide | Solution for injection | 0.1 mg/mL - 1mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
levothyroxine | tablet | 50 mcg (sodium salt) | |
levothyroxine | tablet | 100 mcg (sodium salt) | |
methimazole | tablet | 5 mg | |
propylthiouracil | tablet | 50 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
warfarin | tablet | 5 mg (sodium salt) | |
heparin sodium | Injection | 5000 IU/mL in 1-mL ampoule | |
enoxaparin | Injection | 20 mg/ml | |
enoxaparin | Injection | 60 mg (sodium) | |
clopidogrel | tablet | 75 mg | |
acetylsalicylic acid | tablet | 80 to 100 mg | |
streptokinase | Powder for injection | 1.5 million IU in vial |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
aminocaproic acid | Injection | 250mg/ml | |
phytomenadione | Injection | 10 mg/mL in 1-mL vial | |
prothrombin complex concentrate | Injection | 500 a 600 UI | |
prothrombine activate complex (CCPa) or anticoagulant anti-inhibitor complex | Injection | 500 UF | |
factor VIII | Solution for injection | 500 UI | |
factor IX | Powder for injection | 500 UI a 600 UI |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
erythropoietin alpha | Injection | 4000 U/ ml | |
folic acid | tablet | 5 mg | |
cyanocobalamin | Injection | 1000 mcg/ml | |
ferrous sulfate + folic acid | tablet | 300mg + 0.5mg | |
ferrous sulfate | oral liquid | 125mg/ml | |
ferrous sulfate | tablet | 300 mg | |
erythropoietin beta | Solution for injection | 50000 UI |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
albumin | Injection | 20%-25% | |
plasmatic volumen expander gelatin based | Solution | 3.5-4% | |
dextrose | N/A | 5% | |
dextrose | Injection | 10% | |
dextrose | N/A | 50% | |
ringer lactate solution | N/A | N/A | |
dextrose + sodio chloruro | Solution for injection | 5% + 0.9% - 1000 mL. | |
dextrose + sodium chlorure | Solution for IV infusion | 5 + 0.3% | |
mannitol | intravenous administration | 20% | |
chloruro de sodio | Solution for injection | 0.9 % | |
chloruro de sodio | parenteral solution | 20% | |
peritoneal dialysis solution | Solution | Dextrose 1.5% - 2000 mL. | |
intraperitoneal dialysis solution (of appropriate composition) | Solution for IV infusion | 2.5% glucose | |
intraperitoneal dialysis solution (of appropriate composition) | parenteral formulation | 4.5% | |
potassium chloride | Injection | 20 mEq/10 ml | |
potassium chloride | Solution | 2 mEq/ml | |
sodium bicarbonate | Injection | 8.4% | |
magnesium sulfate | Injection | 50% x 2 ml | |
calcium chloride | Injection | 5% | |
sodium chloride + phenol (preservant) | Injection | 0.9 + 0.4% | |
hemodialysis solution | Solution for IV infusion | N/A | |
hemodialysis solution (concentrated, acid, for bicarbonate hemodialysis) | N/A | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
propranolol | tablet | 10mg (hydrochloride) | |
propranolol | tablet | 40 mg (hydrochloride) | |
propranolol | Injection | 1mg/ml | |
atenolol | tablet | 100 mg | |
esmolol | Injection | 250 mg/ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
carvedilol | tablet | 6.25 mg | |
carvedilol | tablet | 25 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amlodipine | tablet | 5 mg (besylate) | |
amlodipine | Injection | 5 mg/mL | |
nifedipine | N/A | 30 mg | |
nifedipine | tablet | 10 mg | |
nimodipine | tablet | 30 mg. | |
nimodipine | Injection | 0.2 mg/mL | |
nimodipine | tablet | 30 mg | |
verapamil | tablet | 80 mg (hydrochloride) | |
verapamil | Injection | 2.5 mg/mL | |
verapamil | N/A | 240 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
enalapril | tablet | 5 mg (maleate) | |
enalapril | tablet | 20 mg (maleate) | |
Ibersartan | tablet | 150 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
atorvastatine | tablet | 10 mg | |
atorvastatine | tablet | 40 mg (calcium salt) | |
ciprofibrato | capsule | 100 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
methyldopa | tablet | 500mg | |
hydralazine | tablet | 50 mg (hydrochloride) | |
hydralazine | Injection | 20 mg | |
sodium nitroprusside | Injection | 25 mg/mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
hydrochlorothiazide | tablet | 25 mg | |
furosemide | tablet | 40 mg | |
furosemide | Injection | 10 mg/mL in 2-mL ampoule | |
spironolactone | tablet | 25 mg | |
spironolactone | tablet | 100mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
digoxin | tablet | 0.25 mg | |
digoxin | eli | 0.05 mg/ml | |
digoxin | Injection | 0.25 mg/ml | |
amiodarone | tablet (HCI) | 200 mg (hydrochloride) | |
amiodarone | Injection | 50 mg/ml | |
norepinephrine | Injection | 1 mg (bitartrate)/mL | |
dopamine | Injection | 40 mg/ml | |
phenylephrine | Injection | 10 mg in 1-mL ampoule | |
dobutamine | Injection | 12.5mg (hydrochloride)/mL in 20 ml vial | |
epinephrine (adrenaline) | Injection | 1 mg in 1-mL ampoule | |
ephedrine | Injection | 25 mg/ml | |
glyceryl trinitrate | Solution for injection | 5 mg/ ml | |
glyceryl trinitrate | patch | 18-25 mg | |
isosorbide dinitrate | tablet (sublingual) | 5 mg | |
isosorbide dinitrate | tablet | 40 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
antihemorrhoidal preparation (corticosteroid + local anesthetic) | Ointment | 30 gr/ 60 gr. | |
polidocanol | intravenous administration | 3% in 20-mL ampoule |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
metronidazole | Gel | 0.75% | |
clotrimazole | vaginal cream | 1% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ethinylestradiol + levonorgestrel | tablet | 30 mcg + 150 mcg | |
levonorgestrel | implant | 75 mg | |
medroxyprogesterone | Powder for injection | 150 mg in vial | |
etonogestrel | implant | 68 mg. | |
levonorgestrel | tablet | 1.5 mg | |
estradiol | tablet | 1 mg | |
conjugated estrogens | tablet | 0.625 mg | |
progesterone | tablet | 100 mg | |
norethisterone enantate + estradiol valerate | Injection | 50 mg/5 mg | |
chorionic gonadotropin | Injection | 2500 UI | |
clomifene | tablet | 50 mg (citrate) | |
danazol | tablet | 200 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ergonovina maleato | Injection | 0.2 mg/ ml | |
misoprostol | tablet | 200 mcg | |
bromocriptine mesylate | tablet | 2.5 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
Oxibutinine Hidrochloride | tablet | 5mg. | |
terazosin | tablet | 5 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
alendronic acid | tablet | 70mg (as alendronate sodium) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
allopurinol | tablet | 300 mg | |
colchicine | tablet | 0.5mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
indomethacin | tablet | 25 mg | |
diclofenac | Injection | 25 mg (sodium)/mL | |
diclofenac (sodium) | tablet | 50mg | |
diclofenac | Suspension | 15mg/5mL | |
ketorolac | Injection | 30mg/ml | |
ibuprofen | tablet | 400 mg | |
ibuprofen | Suspension | 100 mg/5 mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
suxamethonium | Injection | 500mg | |
suxamethonium | Injection | 100mg/ml | |
pancuronium | Injection | 2 mg (bromuro)/mL | |
vecuronium | Injection | 4 mg (bromide)/mL in ampoule | |
cisatracurium | Injection | 2 mg/ml | |
metocarbamol | Injection | 500mg | |
orfenadrine | Injection | 30mg (citrate)/ml in 2ml vial | |
Tizanidine hydrochloride | tablet | 4 mg. |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
morphine | tablet | 30 mg (sulfate) | |
morphine | oral liquid | 10 mg (sulfate)/5 mL | |
oxycodone | tablet | 10 mg | |
acetaminofen + oxycodone | tablet | 325+5 mg | |
pethidine | Injection | 50 mg (hydrochloride) in 1-mL ampoule | |
fentanyl | Injection | 0.05 mg/mL | |
nalbuphine hydrochloride | Solution for injection | 10 mg/ml | |
tramadol | tablet | 50 mg (hydrochloride) | |
tramadol | Injection | 50 mg (hydrochloride)/mL | |
tramadol | oral liquid | 100 mg (hydrochloride)/mL (as drops) | |
acetaminofen | tablet | 500 mg | |
paracetamol/ acetaminophen | Syu | 120 mg/ 5 ml | |
acetaminofen | tablet | 250 -300 mg | |
acetaminofen | tablet | 125 mg | |
ergotamine + caffeine | tablet | 1 mg (tartrate) + 100 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
halothane | inhalation | N/A | |
isoflurane | inhalation | N/A | |
sevoflurane | inhalation | N/A | |
thiopental | Injection | 1 g (as sodium) | |
remifentanil | Injection | 2 mg | |
remifentanil | Injection | 5mg | |
ketamine | Injection | 50 mg/mL | |
etomidate | Injection | 2mg/ml | |
propofol | Injection | 10 mg/mL | |
propofol | Injection | 20 mg/mL | |
bupivacaine | Injection | 0.5% (hydrochloride) in vial | |
lidocaine | Injection | 2% (hydrochloride) in vial | |
lidocaine | solution topical | 10% (100mg/mL) | |
mepivacaine | dental cartridge | 3% | |
bupivacaine + dextrosa | Injection | 0.5%/ 8% (80 mg/ ml) | |
lidocaine + epinephrine (adrenaline) | Injection | 2% | |
mepivacaina + epinefrina | Injection | 2% / 1:100 000 |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
phenobarbital | tablet | 100 mg | |
phenobarbital | oral liquid | 20 mg/5mL (0.4%) | |
phenobarbital | Suspension | 65mg/mL | |
phenytoin | solid oral dosage form | 100 mg (sodium salt) | |
phenytoin | Injection | 50 mg/mL in 5-mL vial (sodium salt) | |
phenytoin | Suspension | 125 mg/ 5 ml x 240 ml | |
clonazepam | tablet | 2mg | |
carbamazepine | tablet | 200 mg | |
oxcarbazepine | N/A | 60mg/mL | |
valproic acid (sodium valproate) | tablet | 500 mg | |
valproic acid (sodium valproate) | oral liquid | 250 mg/5 mL | |
valproic acid (sodium valproate) | Solution | 200 mg/ml | |
valproic acid (sodium valproate) | Injection | 100mg/mL | |
topiramate | tablet | 25 mg | |
levetiracetam | tablet | 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
biperiden | tablet | 2 mg (hydrochloride) | |
biperiden | Injection | 5 mg (lactate) in 1-ml ampoule | |
levodopa + carbidopa | tablet | 250 mg + 25 mg | |
amantadine | capsule | 100 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
neostigmine | Injection | 0,5 mg/ml | |
pyridostigmine | tablet | 60 mg | |
methadone | concentrate for oral liquid | 10 mg/ml (hydrochloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
imipramine chlorohydrate | tablet | 25mg | |
imipramine chlorohydrate | tablet | 10 mg | |
clomipramine | tablet | 25 mg | |
amitriptyline | tablet | 25 mg (hydrochloride) | |
fluoxetine | tablet | 20 mg | |
sertraline | tablet | 50 mg (chlorohydrate) | |
duloxetine | tablet | 60 mg | |
cafeine citrate | Injection | 20mg/mL | |
methylphenidate | tablet | 10 mg (hydrochloride) | |
memantina | tablet | 10 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
chlorpromazine | tablet | 100 mg (hydrochloride) | |
chlorpromazine | Injection | 25 mg (hydrochloride)/mL in 2-mL ampoule | |
flufenazine decanoate | N/A | 25mg/mL | |
haloperidol | tablet | 5 mg | |
haloperidol | oral liquid | 2 mg/mL | |
haloperidol | Injection | 5 mg (decanoate)/mL | |
clozapine | tablet | 100mg | |
olanzapine | tablet | 10 mg | |
lithium carbonate | tablet | 300 mg | |
risperidone | tablet | 2mg | |
risperidone | Solution | 1 mg/ml | |
diazepam | Injection | 5 mg/mL | |
lorazepam | tablet | 2 mg. | |
midazolam | Injection | 5 mg/mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
salbutamol | respirator solution for use in nebulizers | 0.5% | |
salbutamol | inhalation (aerosol) | 100 mcg (as sulfate) per dose | |
formoterol | inhalation |